Literature DB >> 1445492

Paradoxical response of plasma lipoprotein(a) in patients undergoing cardiopulmonary bypass.

D S Sgoutas1, O M Lattouf, D C Finlayson, R V Clark.   

Abstract

Plasma lipid, lipoprotein and apolipoprotein levels are known to decrease after major surgery. Coronary artery bypass surgery additionally involves use of extracorporeal circulation by use of a cardiopulmonary bypass pump, which necessitates hemodilution due to saline dextrose infusion to prime the pump. To investigate changes in lipids, lipoproteins and apolipoproteins as well as changes in C-reactive protein and albumin we conducted a study on 22 patients undergoing cardiac surgery involving cardiopulmonary bypass. Timed arterial blood samples were taken before, during and after cardiopulmonary bypass. At the onset and during cardiopulmonary bypass a rapid and significant fall was observed in all lipids and lipoproteins except lipoprotein(a) with recovery to near basal levels by 72 h for cholesterol, triglycerides, high density lipoprotein cholesterol and albumin, while apolipoproteins AI and B remained below basal levels during the postoperative period up to 72 h. In contrast, lipoprotein(a) levels increased at the onset, doubled during cardiopulmonary bypass and remained elevated postoperatively. On the other hand, C-reactive protein levels fell at the onset and during cardiopulmonary bypass but they became markedly elevated postoperatively. When results were corrected for hemodilution, the response patterns remained unchanged. As lipoprotein(a) is both atherogenic and thrombogenic, its elevation during cardiopulmonary bypass may be clinically important.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1445492     DOI: 10.1016/0021-9150(92)90048-l

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  3 in total

1.  Lipoprotein (a) does not participate in the early acute phase response to training or extreme physical activity and is unlikely to enhance any associated immediate cardiovascular risk.

Authors:  D J Byrne; I A Jagroop; H E Montgomery; M Thomas; D P Mikhailidis; N G Milton; A F Winder
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

2.  Metabolic profiling of plasma from cardiac surgical patients concurrently administered with tranexamic acid: DI-SPME-LC-MS analysis.

Authors:  Barbara Bojko; Marcin Wąsowicz; Janusz Pawliszyn
Journal:  J Pharm Anal       Date:  2013-04-11

3.  CB2R Activation Regulates TFEB-Mediated Autophagy and Affects Lipid Metabolism and Inflammation of Astrocytes in POCD.

Authors:  Lieliang Zhang; Xifeng Wang; Wen Yu; Jun Ying; Pu Fang; Qingcui Zheng; Xiaojin Feng; Jialing Hu; Fan Xiao; Shoulin Chen; Gen Wei; Yue Lin; Xing Liu; Danying Yang; Yang Fang; Guohai Xu; Fuzhou Hua
Journal:  Front Immunol       Date:  2022-03-22       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.